We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

96 hedge funds and large institutions have $126M invested in Xeris Biopharma Holdings in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

335% more call options, than puts

Call options by funds: $11.3M | Put options by funds: $2.6M

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

50% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 24

12% more funds holding

Funds holding: 86 → 96 (+10)

2.23% less ownership

Funds ownership: 54.59% → 52.37% (-2.2%)

16% less capital invested

Capital invested by funds: $150M → $126M (-$23.4M)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
36
Reduced
24
Closed
13
Calls
$11.3M
Puts
$2.6M
Net Calls
+$8.7M
Net Calls Change
-$4.28M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$939K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$727K
3
Goldman Sachs
Goldman Sachs
New York
+$700K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$675K
5
Two Sigma Investments
Two Sigma Investments
New York
+$636K

Top Sellers

Rank Fund Capital Flow
1
Voloridge Investment Management
Voloridge Investment Management
Florida
-$1.42M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.21M
3
MCM
Moore Capital Management
New York
-$1.04M
4
AGM
Alpine Global Management
New York
-$1.01M
5
DAM
Deltec Asset Management
New York
-$797K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$671K +$505K +100,946 +285%
Voloridge Investment Management
27
Voloridge Investment Management
Florida
$663K -$1.42M -284,301 -68%
Two Sigma Investments
28
Two Sigma Investments
New York
$625K +$636K +127,094 New
MMA
29
Miracle Mile Advisors
California
$587K +$145K +29,000 +32%
Charles Schwab
30
Charles Schwab
California
$580K +$51.9K +10,377 +10%
Renaissance Technologies
31
Renaissance Technologies
New York
$504K +$186K +37,254 +57%
Lazard Asset Management
32
Lazard Asset Management
New York
$475K +$341K +68,194 +240%
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$468K +$5K +1,000 +1%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$460K -$10K -2,000 -2%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$382K – – –
Lido Advisors
36
Lido Advisors
California
$359K +$365K +73,000 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$342K – – –
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$319K +$324K +64,800 New
Citadel Advisors
39
Citadel Advisors
Florida
$289K +$177K +35,391 +151%
GIA
40
Gladstone Institutional Advisory
Florida
$253K +$258K +51,500 New
GWSG
41
GPS Wealth Strategies Group
Colorado
$226K +$2.63K +525 +1%
CSS
42
Cubist Systematic Strategies
Connecticut
$223K +$227K +45,397 New
KSCM
43
Kamunting Street Capital Management
Florida
$216K -$281K -56,167 -56%
Wells Fargo
44
Wells Fargo
California
$215K +$91.1K +18,204 +71%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$213K +$28.2K +5,630 +15%
HH
46
Hilltop Holdings
Texas
$212K +$215K +43,000 New
Morgan Stanley
47
Morgan Stanley
New York
$202K +$152K +30,292 +279%
CWM
48
Cornerstone Wealth Management
Missouri
$180K -$150K -30,000 -45%
TC
49
TownSquare Capital
Utah
$177K +$79.1K +15,811 +78%
AllianceBernstein
50
AllianceBernstein
Tennessee
$173K – – –
1
2
3 4 5

XERS Hedge Fund Activity: Q4 2020 in Review

96 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q4 2020, worth a combined $126M — down 16% from $150M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new XERS positions and 13 closed out — a net gain of 10 holders — while 36 added to existing stakes and 24 trimmed.

The largest buyer was Vanguard Group, adding an estimated $939K. The largest seller was Voloridge Investment Management, cutting an estimated $1.42M.

  • 96 institutional investors held Xeris Biopharma Holdings (XERS) as of Q4 2020, up from 86 in Q3 2020.
  • Funds reported $126M of Xeris Biopharma Holdings stock for Q4 2020, down 16% quarter-over-quarter.
  • 23 funds opened new Xeris Biopharma Holdings positions in Q4 2020 and 13 closed out, a net change of +10 holders.
  • The largest Xeris Biopharma Holdings buyer in Q4 2020 was Vanguard Group, an estimated $939K added.
  • The largest Xeris Biopharma Holdings seller in Q4 2020 was Voloridge Investment Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q4 2020.